ReviewFrontiers in oncology2024

ILF2: a multifaceted regulator in malignant tumors and its prospects as a biomarker and therapeutic target.

Tonglin Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.